CN121772922A - 甲癣用外用剂 - Google Patents

甲癣用外用剂

Info

Publication number
CN121772922A
CN121772922A CN202480049777.9A CN202480049777A CN121772922A CN 121772922 A CN121772922 A CN 121772922A CN 202480049777 A CN202480049777 A CN 202480049777A CN 121772922 A CN121772922 A CN 121772922A
Authority
CN
China
Prior art keywords
solvent
onychomycosis
lower alcohols
group
dimethyl sulfoxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202480049777.9A
Other languages
English (en)
Chinese (zh)
Inventor
石桥优
八木隆晴
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ishihara Sangyo Kaisha Ltd
Original Assignee
Ishihara Sangyo Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ishihara Sangyo Kaisha Ltd filed Critical Ishihara Sangyo Kaisha Ltd
Publication of CN121772922A publication Critical patent/CN121772922A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CN202480049777.9A 2023-08-02 2024-08-02 甲癣用外用剂 Pending CN121772922A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2023125977 2023-08-02
JP2023-125977 2023-08-02
PCT/JP2024/027707 WO2025028651A1 (ja) 2023-08-02 2024-08-02 爪白癬用外用剤

Publications (1)

Publication Number Publication Date
CN121772922A true CN121772922A (zh) 2026-03-31

Family

ID=94395367

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202480049777.9A Pending CN121772922A (zh) 2023-08-02 2024-08-02 甲癣用外用剂

Country Status (7)

Country Link
JP (1) JPWO2025028651A1 (https=)
KR (1) KR20260046477A (https=)
CN (1) CN121772922A (https=)
AU (1) AU2024318152A1 (https=)
MX (1) MX2026000870A (https=)
TW (1) TW202519215A (https=)
WO (1) WO2025028651A1 (https=)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007102243A1 (ja) 2006-03-08 2007-09-13 Nihon Nohyaku Co., Ltd. 外用の医薬組成物
RU2419429C2 (ru) 2006-03-08 2011-05-27 Нихон Нохияку Ко.,Лтд. Фармацевтическая композиция для наружного применения
KR101409792B1 (ko) 2009-04-09 2014-06-19 니혼노야쿠가부시키가이샤 항진균성 약제학적 조성물
MX2020004491A (es) * 2017-10-30 2020-08-13 Kaken Pharma Co Ltd Preparacion externa para tratar tinea unguium.
WO2019150485A1 (ja) * 2018-01-31 2019-08-08 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 爪白癬の予防又は治療用外用液剤
WO2020231800A1 (en) 2019-05-10 2020-11-19 Encube Ethicals Private Limited Topical antifungal formulation
BR112022024702A2 (pt) 2020-06-03 2023-02-28 Ishihara Sangyo Kaisha Agente antifúngico para ser humano
JP7780094B2 (ja) * 2020-06-03 2025-12-04 石原産業株式会社 非ヒト動物用抗菌剤
TW202330476A (zh) 2021-12-08 2023-08-01 日商石原產業股份有限公司 ５－氯－４－（３－氯－４－甲基苯基）－１ｈ－咪唑－２－甲腈之水合物結晶

Also Published As

Publication number Publication date
KR20260046477A (ko) 2026-04-07
WO2025028651A1 (ja) 2025-02-06
TW202519215A (zh) 2025-05-16
MX2026000870A (es) 2026-03-02
JPWO2025028651A1 (https=) 2025-02-06
AU2024318152A1 (en) 2026-02-05

Similar Documents

Publication Publication Date Title
RU2419429C2 (ru) Фармацевтическая композиция для наружного применения
EP3612228B1 (en) Iodine compositions
JP6582158B1 (ja) 爪白癬治療用の外用製剤
KR20150119037A (ko) 특이한 정벽을 가지는 결정형 및 이 결정형을 유효 성분으로서 함유하는 약학 조성물
TW201201809A (en) Topical formulation for a JAK inhibitor
KR20220050236A (ko) 감염 치료용 조성물, 시스템, 키트, 및 방법
KR20090031726A (ko) 국소용 조성물
EP2266626A1 (en) Composition for external application comprising transcription factor decoy as active ingredient
US7199159B2 (en) Use of biguanide derivatives for making a medicine having a wound healing effect
HUE030464T2 (en) Caspofungin preparation
JP2010517987A (ja) 塩基性ペプチド及びその複合型抗細菌−抗真菌剤としての使用
RU2398578C2 (ru) Фармацевтическая композиция, содержащая производное таксана, которая предназначена для приготовления инфузионного раствора, способ его приготовления и использование
JP4171086B2 (ja) ポリ（ヘキサメチレン）ビグアニドまたはその塩を有効成分とする腫瘍治療剤
KR20210088528A (ko) 진균 감염을 치료하기 위한 화합물 및 방법
WO1988006884A1 (en) A pharmaceutical composition used for the topical treatment of nail mycosis and a process for preparing same
CN121772922A (zh) 甲癣用外用剂
JP6974496B2 (ja) Ｈｉｆプロリルヒドロキシラーゼ活性の阻害剤としてのカンナビジオール誘導体
JP6625208B2 (ja) 経皮製剤
TWI920017B (zh) 用於治療真菌感染之化合物及方法
EA017028B1 (ru) Антибактериальная композиция
CN1284873A (zh) 水性液体制剂
JP4209488B2 (ja) 皮膚創傷治療剤
HK40024555B (en) External preparation for treating trichophytosis unguium
HK40024555A (en) External preparation for treating trichophytosis unguium
HK40112488A (zh) 局部使用akt抑制剂来预防、治疗和改善皮肤疾病、病况和病症的组合物和制剂

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination